Cohen & Steers Executive Chairman Robert Hamilton purchased 25,000 shares for $1,496,880.00 on 2025-11-19 at $59.88 blended average, amid -44.2% YTD decline from 52-week high.
Robert Hamilton executed 2 separate open-market purchases totaling 25,000 shares (25.0K shares) for $1,496,880.00 ($1.5M) at blended average $59.88 on 2025-11-19, increasing his holdings from 3.87M to 3.90M shares (+0.6%). This follows a burst of recent buying activity at the same ticker—5 prior trades in early November 2025 (2025-11-03 through 2025-11-05), all outcomes not yet measurable. The timing context is material: CNS stock trades -44.2% from its 52-week high of $106.60, with 30-day and 90-day declines of -15.9% and -22.0% respectively. However, his prior cross-ticker buys (18 trades) averaged -15.2% 30-day returns, and his 0 of 0 prior buys at this or any ticker showed positive 90-day outcomes, suggesting a pattern of purchases that have not proven well-timed historically. Fundamentals remain stable (P/E 18.47, $141.7M quarterly revenue, +5.7% annual growth), but the convergence of sharply negative recent price action, frequent insider acquisitions in November, and a track record of sub-optimal timing on buys warrants attention to whether this accumulation is informed conviction or routine portfolio activity.